Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, on what date the Oxford–AstraZeneca covid-19 vaccine Vaxzevria was withdrawn from general public administration in the UK; and for what reason.

AstraZeneca completed its COVID-19 vaccine supply agreement with the Government in 2022. Since the beginning of the COVID-19 vaccine booster programme in September 2021, in line with advice from the Joint Committee on Vaccination and Immunisation, the vaccines deployed in the national programme have primarily been mRNA vaccines that were considered to provide a strong booster response.